Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Ongoing Initiated Oct 15, 2015 (11 years ago)

Dryses Aluminum Chlorohydrate Deodorant for Men Roll-on

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

cGMP Deviations; product does not comply with cGMP requirements

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

Dryses Aluminum Chlorohydrate Deodorant for Men Roll-on, 2.5 fl oz (75 mL) bottle, over the counter, Manufactured by Sesderma S.L., Valencia, Spain, NDC 63181-0019-1 UPC 8 470002 075221

Affected NDC 63181-0019-01

Compare with the code on your package — it is the most precise check available.

Recalling firm
Sesderma, SL
NDC code
63181-0019-1
Origin
N/A, Spain
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0846-2016 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall.

Other recalls by Sesderma, SL

All 2015 recalls
Class II · Moderate risk

Repaskin 30

cGMP Deviations; product does not comply with cGMP requirements

Ongoing cGMP deviation Sesderma, SL NDC 63181-0010-1 D-0849-2016
Class II · Moderate risk

Repaskin 50

cGMP Deviations; product does not comply with cGMP requirements

Ongoing cGMP deviation Sesderma, SL NDC 63181-0011-1 D-0848-2016

Other cgmp deviation recalls from 2015

All cgmp deviation recalls
Class II · Moderate risk

Oxygen

cGMP Deviations; trailer may not have met GMP requirements prior to filling

Terminated cGMP deviation AGA Gas Inc NDC 33237-001-01 D-0779-2016
Class II · Moderate risk

Repaskin 30

cGMP Deviations; product does not comply with cGMP requirements

Ongoing cGMP deviation Sesderma, SL NDC 63181-0010-1 D-0849-2016